MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


RNS News Service

I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.

Willis Towers Watson plc 8.3

RNS

RNS Number : 3812D
J.P. Morgan Securities LLC
27 October 2020
 

Ap19

 

 

FORM   8.3

 

IRISHTAKEOVERPANEL

 

DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997, TAKEOVERRULES,2013

 

DEALINGS BY PERSONSWITHINTERESTSINRELEVANTSECURITIES REPRESENTING 1%ORMORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

26 October 2020

 

2.  INTERESTS ANDSHORTPOSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 2,318,344  1.80

2,298,039  1.78

(2) Derivatives (other than options)

 2,215,671  1.72

2,242,859  1.74

(3)Optionsandagreementstopurchase/sell

 

 

Total

 4,534,015  3.52

4,540,898  3.52

             

 

 

Ap20

 

 

1.  DEALINGS (Note   4)

 

(a)  Purchasesandsales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit(USD)

 

(Note 5)

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

1

299

1

4,412

1

28

700

1,100

1

1

1

60

100

3

 

269

2

533

2

100

1,512

100

100

754

1,492

5,522

7

7,813

3,168

52

97

100

1,100

200

808

1,631

680

100

137

15

20

2,510

456

2

3

30

3

202.1300

202.9204

203.1800

203.2800

203.3000

203.3750

203.5986

203.8348

204.2000

205.4900

206.8250

207.8800

208.1731

209.7500

 

201.7399

202.1600

202.1704

202.2400

202.3800

202.3974

202.4950

202.6400

203.0049

203.2189

203.2800

203.3100

203.4463

203.4767

203.5600

203.6500

203.7700

203.8348

203.8550

203.9089

203.9349

203.9360

203.9500

203.9687

203.9700

203.9900

204.0022

204.0220

204.0900

204.2000

207.8800

209.7500

 

 

(b)  Derivativestransactions(otherthanoptionstransactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD)

(Note 5)

Equity Swap

Long

 

Short

6

 

1,100

30

203.2800

 

203.8348

207.8800

 

 

(c)  Optionstransactionsinrespectofexistingrelevantsecurities

 

 

(i)  Writing,selling,purchasingorvarying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements,arrangements orunderstandingsrelatingtooptionsorderivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing 

and any other person relating to the voting rights of any relevant securities under any option 

referred   to   on   this   form   or   relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any  

relevant securities to which any derivative referred to on this form is referenced. If none, this shouldbestated.

 

  None

 

 

 

 

 

 

 

 

IsaSupplementalForm8attached?  (Note   9)    NO

 

Dateofdisclosure

27 October 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEEDLFLBBLFFBD